The Only Complete Online Marketing Firm
Sunday, March 1, 2015
Adjuvant VEGF Blockers Disappoint in Kidney Cancer
(MedPage Today) -- Survival no better with post-surgical sunitinib or sorafenib than with placebo.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment